Emergent Biosolutions Inc (EBS) — Working Capital to Net Assets Ratio
Emergent Biosolutions Inc (EBS) has a Working Capital to Net Assets ratio of 93.5% as of March 2026. Working capital of $488.90 Million (current assets of $637.60 Million minus current liabilities of $148.70 Million) is measured against net assets of $523.10 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See EBS free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Emergent Biosolutions Inc Working Capital to Net Assets (2001–2025)
This chart shows how Emergent Biosolutions Inc's Working Capital to Net Assets ratio has evolved across 23 annual periods from 2001 to 2025. As of March 2026, the ratio stands at 93.5%, reflecting working capital of $488.90 Million against net assets of $523.10 Million USD. See Emergent Biosolutions Inc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Emergent Biosolutions Inc (2001–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Emergent Biosolutions Inc from 2001 to 2025, covering 23 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see how much is Emergent Biosolutions Inc worth.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 101.5% | $530.30 Million | $522.60 Million | $662.50 Million | $132.20 Million | ▲ +11.1 pp |
| 2024 | 90.4% | $436.30 Million | $482.80 Million | $598.70 Million | $162.40 Million | ▲ +86.0 pp |
| 2023 | 4.3% | $28.20 Million | $649.30 Million | $679.50 Million | $651.30 Million | ▲ +5.7 pp |
| 2022 | -1.3% | $-18.50 Million | $1.39 Billion | $1.21 Billion | $1.23 Billion | ▼ -56.9 pp |
| 2021 | 55.6% | $895.90 Million | $1.61 Billion | $1.27 Billion | $374.00 Million | ▼ -0.5 pp |
| 2020 | 56.1% | $811.40 Million | $1.45 Billion | $1.20 Billion | $384.50 Million | ▲ +12.9 pp |
| 2019 | 43.2% | $469.90 Million | $1.09 Billion | $686.20 Million | $216.30 Million | ▲ +1.6 pp |
| 2018 | 41.6% | $420.40 Million | $1.01 Billion | $620.80 Million | $200.40 Million | ▼ -0.6 pp |
| 2017 | 42.2% | $385.32 Million | $912.35 Million | $485.39 Million | $100.07 Million | ▼ -25.6 pp |
| 2016 | 67.8% | $404.36 Million | $596.21 Million | $510.22 Million | $105.86 Million | ▲ +1.3 pp |
| 2015 | 66.5% | $439.00 Million | $660.02 Million | $538.61 Million | $99.61 Million | ▲ +5.2 pp |
| 2014 | 61.3% | $339.24 Million | $553.20 Million | $432.18 Million | $92.94 Million | ▲ +17.1 pp |
| 2013 | 44.3% | $216.46 Million | $489.17 Million | $273.12 Million | $56.65 Million | ▼ -1.3 pp |
| 2012 | 45.6% | $201.44 Million | $442.13 Million | $263.35 Million | $61.91 Million | ▲ +1.6 pp |
| 2011 | 44.0% | $183.36 Million | $416.73 Million | $254.42 Million | $71.05 Million | ▼ -0.9 pp |
| 2010 | 44.9% | $167.77 Million | $373.56 Million | $243.49 Million | $75.72 Million | ▼ -12.1 pp |
| 2009 | 57.1% | $139.11 Million | $243.81 Million | $193.81 Million | $54.70 Million | ▲ +7.6 pp |
| 2008 | 49.5% | $98.66 Million | $199.35 Million | $152.68 Million | $54.02 Million | ▼ -2.3 pp |
| 2007 | 51.8% | $88.65 Million | $171.16 Million | $144.31 Million | $55.66 Million | ▼ -8.1 pp |
| 2006 | 59.9% | $82.99 Million | $138.47 Million | $147.34 Million | $64.35 Million | ▲ +11.3 pp |
| 2005 | 48.6% | $29.02 Million | $59.74 Million | $59.12 Million | $30.09 Million | ▲ +15.9 pp |
| 2004 | 32.7% | $7.51 Million | $22.95 Million | $41.70 Million | $34.19 Million | ▲ +2545.2 pp |
| 2001 | -2512.5% | $811.40 Million | $-32.30 Million | $1.20 Billion | $384.50 Million | — |